New Haven, CONNECTICUT3 Active Studies

Amyloidosis Clinical Trials in New Haven, CONNECTICUT

Find 3 actively recruiting amyloidosis clinical trials in New Haven, CONNECTICUT. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,120
Enrolling

Recruiting Amyloidosis Studies in New Haven

About Amyloidosis Clinical Trials in New Haven

Amyloidosis is a group of diseases in which abnormal proteins (amyloids) build up in organs and tissues, impairing their function. Types include AL, AA, and ATTR amyloidosis. Treatment depends on the type and may include chemotherapy, organ transplant, or targeted therapies.

There are currently 3 amyloidosis clinical trials recruiting participants in New Haven, CONNECTICUT. These studies are seeking a combined 1,120 participants. Research is being sponsored by Eidos Therapeutics, a BridgeBio company, SWOG Cancer Research Network, Sharmila Dorbala. Clinical trial participation is free and participants receive study-related medical care at no cost.

Amyloidosis Clinical Trials in New Haven — FAQ

Are there amyloidosis clinical trials in New Haven?

Yes, there are 3 amyloidosis clinical trials currently recruiting in New Haven, CONNECTICUT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What amyloidosis treatments are being tested?

The 3 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for amyloidosis.

Data updated March 2, 2026 from ClinicalTrials.gov